Handa Pharmaceuticals, Inc.

NT$104.50As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6620Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 0.85%
Div yield 1.91%
ROE 10.60%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.67
PE TTM 34.62
TSR TTM (15.69%)
Mkt cap NT$16.98B
ROIC 24.98%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$125
20.05%
(62.55%)
Hold 10|4|1|2|11
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
1.38
1.42
1.48
1.48
12.37%
7.77%
17.14%
7.93%
RevenueNT$M
795.8
821.8
812.4
847.6
1.63%
2.62%
1.22%
8.43%
Peers (US$513.0M)
Cap (US$)
PE
473.0M
17.48x
444.5M
17.80x
511.9M
—
Capital
TTM
5Y
10Y
Leveragex
0.051
(4.951)
(3.477)
EBIT/Intx
0.883
0.084
0.086
Own earn%
79.43
44.86
3.66
Sh yield%
44.22
32.73
32.98
Owners
Insiders/Inst%
7.00
51.30
Short interest%
4.50
SBC / revenue%
3.15
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
9–18
$1 testx
−0.1
Incr. ROIC%
5